Mizuma Atsushi, Kouchi Maiko, Netsu Shizuka, Yutani Sachiko, Kitao Ruriko, Suzuki Shigeaki, Murata Kenya, Nagata Eiichiro, Takizawa Shunya
Department of Neurology, Tokai University School of Medicine, Japan.
Department of Neurology, National Hakone Hospital, Japan.
Intern Med. 2017;56(14):1915-1918. doi: 10.2169/internalmedicine.56.8134. Epub 2017 Jul 15.
We report the case of a 69-year-old woman with proximal limb muscle weakness, who received post-operative chemotherapy for uterine cancer. Her serum creatinine kinase level was high (10,779 mg/dL) and a muscle biopsy from her left biceps revealed various sizes of muscle fibers accompanied by necrotic and regenerating fibers. She was positive for anti-3 hydroxy-3-methylglutary-coenzyme A reductase (anti-HMGCR) antibodies, but negative for anti-signal recognition particle (anti-SRP) antibodies. She was diagnosed with immune-mediated necrotizing myopathy (IMNM) and treated with prednisolone. Our findings indicate that not only drug-induced myopathy but also paraneoplastic myopathy can be involved in the pathogenesis of IMNM.
我们报告了一例69岁近端肢体肌无力的女性病例,该患者因子宫癌接受了术后化疗。她的血清肌酸激酶水平很高(10779mg/dL),左二头肌肌肉活检显示有各种大小的肌纤维,并伴有坏死和再生纤维。她抗3-羟基-3-甲基戊二酰辅酶A还原酶(抗HMGCR)抗体呈阳性,但抗信号识别颗粒(抗SRP)抗体呈阴性。她被诊断为免疫介导的坏死性肌病(IMNM)并接受了泼尼松龙治疗。我们的研究结果表明,不仅药物性肌病,而且副肿瘤性肌病都可能参与IMNM的发病机制。